German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce 2 billion doses in 2021, up from the previous forecast of 1.3 billion doses, APA reports citing Economic Times.
"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," said the company, referring to the additional dose that could be extracted from each vial of the vaccine.
BioNTech boosts 2021 vaccine supply forecast to 2 billion doses
11 January 2021 18:27 (UTC +04:00)
Europe
Poland says breakthrough on Ukrainian grain unlikely in Warsaw talks
13:32
28 March 2024
Germany will now include questions about Israel in its citizenship test
12:04
28 March 2024
France's Macron says EU-Mercosur proposal is 'very bad deal' on visit to Brazil
09:35
28 March 2024
Malta's parliament approves new president
04:35
28 March 2024